The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 164:50A, February 2007
doi: 10.1176/appi.ajp.164.2.A50
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* February AJP Audio
* Residents' Journal
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Articles

In This Issue

A Terrorist Attack’s Physiologic Legacy

Among people directly exposed to the 1995 Oklahoma City bomb blast, even those without posttraumatic stress disorder (PTSD) show heightened physiologic reactions to reminders of the attack. Tucker et al. (p. 230) found that 60 survivors of the bombing had greater increases in heart rate and blood pressure during interviews about the bombing than Oklahoma City residents who were not closely connected to the explosion. The bombing survivors also had a higher baseline heart rate, and their blood pressure remained elevated after the interview. This sensitivity was independent of PTSD, demonstrating that biological disturbance may persist despite apparent emotional resilience many years after a terrorist attack. Dr. Douglas Delahanty reviews the mental health aspects of terrorist attacks in an editorial on p. 189.


Figure 1
View larger version (45K):
[in this window]
[in a new window]

 

FIGURE 1.



Genetics of Mood Disorders

A study of 708 families bolsters evidence that some of the genes conferring susceptibility to bipolar disorder are shared with schizophrenia. Goes et al. (p. 236) found that mood-incongruent psychotic symptoms of bipolar disorder are transmitted within families and are associated with chromosomal regions 13q21-33 and 2p11-q14. The linkage to 13q21-33 supports previous findings of overlap between bipolar disorder and schizophrenia in this region. Until now, 2p11-q14 has been tied to schizophrenia but not bipolar disorder. Dr. Linda Brzustowicz comments on these findings in an editorial on p. 192. Holmans et al. (p. 248) discovered an association between recurrent, early-onset depression and chromosomal region 15q25-q26. In addition, the genome scan of 656 families indicated that this disorder is related to chromosomes 17p12 and 8p22-p21.3 in a sex-specific fashion. The families were also tested for known DNA markers within region 15q25-q26, and the results appear in a companion article by Levinson et al. (p. 259). This fine-mapping narrowed down the genetic location that appears to confer susceptibility to depression. This locus could account for up to 25% of the increased risk of recurrent, early-onset depression among siblings of individuals with the same disorder. Dr. Peter McGuffin discusses these findings in an editorial on p. 195.

Anxiety at an Early Age

More than half of the adults with anxiety disorders have a childhood history of psychiatric illness, and more than one-third had anxiety disorders at ages 11–15. This continuity emerged from longitudinal assessments of the individuals born during 1972–1973 in Dunedin, New Zealand. Gregory et al. (p. 301) report that among those with anxiety diagnoses at age 32, an early history of depression was also common. For children and adolescents with generalized anxiety disorder, Rynn et al. (p. 290) found that extended-release venlafaxine is an effective treatment. Combined data on 313 participants in two placebo-controlled trials demonstrated that 69% of the venlafaxine patients were greatly improved at the end of 8 weeks, compared to 48% of the placebo patients. The improvements occurred in both children (ages 6–11) and adolescents (ages 12–17). The venlafaxine and placebo groups each had one case of suicidal thoughts or attempts. Extended-release venlafaxine had effects on weight, height, cholesterol level, heart rate, and blood pressure.

Psychoanalytic Therapy for Panic Disorder

Medication and cognitive behavior therapy (CBT) are the most common treatments for panic disorder. Brief psychodynamic psychotherapy may offer a third option. Milrod et al. (p. 265) report a 12-week randomized trial comparing a panic-focused psychodynamic intervention with relaxation training for patients with panic disorder. The response rate for psychodynamic psychotherapy was 73%, compared to 39% for relaxation training. The dropout rates differed as well—7% versus 34%. Response was unrelated to concurrent psychotropic medications. Panic-focused psychodynamic psychotherapy could be valuable when medication or CBT is inappropriate or when neither leads to response.


Related Articles:

Are We Prepared to Handle the Mental Health Consequences of Terrorism?
Douglas L. Delahanty
Am J Psychiatry 2007 164: 189-191. [Full Text] [PDF]

Size Matters: The Unexpected Challenge of Detecting Linkage in Large Cohorts
Linda M. Brzustowicz
Am J Psychiatry 2007 164: 192-194. [Full Text] [PDF]

Homing in on Depression Genes
Peter McGuffin, Sarah Cohen, and Jo Knight
Am J Psychiatry 2007 164: 195-197. [Full Text] [PDF]

Physiologic Reactivity Despite Emotional Resilience Several Years After Direct Exposure to Terrorism
Phebe M. Tucker, Betty Pfefferbaum, Carol S. North, Adrian Kent, Christie E. Burgin, Don E. Parker, Akm Hossain, Haekyung Jeon-Slaughter, and Richard P. Trautman
Am J Psychiatry 2007 164: 230-235. [Abstract] [Full Text] [PDF]

Mood-Incongruent Psychotic Features in Bipolar Disorder: Familial Aggregation and Suggestive Linkage to 2p11-q14 and 13q21-33
Fernando S. Goes, Peter P. Zandi, Kuangyi Miao, Francis J. McMahon, Jo Steele, Virginia L. Willour, Dean F. MacKinnon, Francis M. Mondimore, Barbara Schweizer, John I. Nurnberger, Jr., John P. Rice, William Scheftner, William Coryell, Wade H. Berrettini, John R. Kelsoe, William Byerley, Dennis L. Murphy, Elliot S. Gershon, Bipolar Disorder Phenome Group, J. Raymond DePaulo, Jr., Melvin G. McInnis, and James B. Potash
Am J Psychiatry 2007 164: 236-247. [Abstract] [Full Text] [PDF]

Genetics of Recurrent Early-Onset Major Depression (GenRED): Final Genome Scan Report
Peter Holmans, Myrna M. Weissman, George S. Zubenko, William A. Scheftner, Raymond R. Crowe, J. Raymond DePaulo, Jr., James A. Knowles, Wendy N. Zubenko, Kathleen Murphy-Eberenz, Diana H. Marta, Sandra Boutelle, Melvin G. McInnis, Philip Adams, Madeline Gladis, Jo Steele, Erin B. Miller, James B. Potash, Dean F. MacKinnon, and Douglas F. Levinson
Am J Psychiatry 2007 164: 248-258. [Abstract] [Full Text] [PDF]

Genetics of Recurrent Early-Onset Major Depression (GenRED): Significant Linkage on Chromosome 15q25-q26 After Fine Mapping With Single Nucleotide Polymorphism Markers
Douglas F. Levinson, Oleg V. Evgrafov, James A. Knowles, James B. Potash, Myrna M. Weissman, William A. Scheftner, J. Raymond DePaulo, Jr., Raymond R. Crowe, Kathleen Murphy-Eberenz, Diana H. Marta, Melvin G. McInnis, Philip Adams, Madeline Gladis, Erin B. Miller, Jo Thomas, and Peter Holmans
Am J Psychiatry 2007 164: 259-264. [Abstract] [Full Text] [PDF]

A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Barbara Milrod, Andrew C. Leon, Fredric Busch, Marie Rudden, Michael Schwalberg, John Clarkin, Andrew Aronson, Meriamne Singer, Wendy Turchin, E. Toby Klass, Elizabeth Graf, Jed J. Teres, and M. Katherine Shear
Am J Psychiatry 2007 164: 265-272. [Abstract] [Full Text] [PDF]

Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents: Two Placebo-Controlled Trials
Moira A. Rynn, Mark A. Riddle, Paul P. Yeung, and Nadia R. Kunz
Am J Psychiatry 2007 164: 290-300. [Abstract] [Full Text] [PDF]

Juvenile Mental Health Histories of Adults With Anxiety Disorders
Alice M. Gregory, Avshalom Caspi, Terrie E. Moffitt, Karestan Koenen, Thalia C. Eley, and Richie Poulton
Am J Psychiatry 2007 164: 301-308. [Abstract] [Full Text] [PDF]




This Article
* Full Text (PDF)
* February AJP Audio
* Residents' Journal
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Articles


Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org